Target intelligence / Profile preview

Immunoglobulin kappa variable 3-11 (IGKV3-11)

Target
IGKV3-11
Molecular classification
Immunoglobulin variable region, Variable region of immunoglobulin light chain, Antigen-binding protein domain, Other
01

Overview

Immunoglobulin kappa variable 3-11 (IGKV3-11) is a **variable region gene segment** encoding part of the kappa light chain of immunoglobulins (antibodies) in humans[3][5]. The variable region (V) participates in forming the antigen recognition site of antibodies, contributing to their specificity and diversity through somatic recombination (V-(D)-J rearrangement) and somatic hypermutation[1]. IGKV3-11 serves as one of many variable gene segments recombined during B cell development, determining the antigen specificity of kappa light chain-containing antibodies[5][3]. While IGKV3-11 itself is not a druggable “target” like a receptor or enzyme, its sequence features and usage can be relevant in antibody engineering, diagnostics (such as minimal residual disease tracking in B cell lymphomas), and as a molecular fingerprint in immunopathology and immune repertoire studies[3][2]. Some studies investigate IGKV3 gene family members as potential immunogens or vaccine candidates in B cell malignancies, but IGKV3-11 specifically is not commonly targeted by drugs or therapeutics[4].

Other names
Immunoglobulin kappa variable 3-11IGKV3-11Ig kappa chain V-III region VGIGKV311L6
02

Biological functions

Antigen bindingImmune responseHumoral immunityAntibody diversityB cell receptor function
03

Disease associations

Cancer (notably B-cell lymphoproliferative diseases, e.g., lymphomas, leukemias)Autoimmune diseases (role in antigen-specific responses)Infection (role as part of the antibody response)
04

Biomarkers

Used for clonality and somatic mutation analysis in B cell lymphoma/leukemia diagnostics (antibody gene usage)

Beyond the preview

Go deeper on Immunoglobulin kappa variable 3-11 (IGKV3-11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 3-11 (IGKV3-11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call